Clinical Trial Update: Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial assessing everolimus in breast cancer patients after pre-operative chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)
• Everolimus (everolimus)

Snippet

Sponsor: Organisation for Oncology and Translational Research | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN